Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling
- PMID: 9860897
- PMCID: PMC1533423
- DOI: 10.1289/ehp.98106s61385
Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling
Abstract
Systematic toxicity testing, using conventional toxicology methodologies, of single chemicals and chemical mixtures is highly impractical because of the immense numbers of chemicals and chemical mixtures involved and the limited scientific resources. Therefore, the development of unconventional, efficient, and predictive toxicology methods is imperative. Using carcinogenicity as an end point, we present approaches for developing predictive tools for toxicologic evaluation of chemicals and chemical mixtures relevant to environmental contamination. Central to the approaches presented is the integration of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) and quantitative structure--activity relationship (QSAR) modeling with focused mechanistically based experimental toxicology. In this development, molecular and cellular biomarkers critical to the carcinogenesis process are evaluated quantitatively between different chemicals and/or chemical mixtures. Examples presented include the integration of PBPK/PD and QSAR modeling with a time-course medium-term liver foci assay, molecular biology and cell proliferation studies. Fourier transform infrared spectroscopic analyses of DNA changes, and cancer modeling to assess and attempt to predict the carcinogenicity of the series of 12 chlorobenzene isomers. Also presented is an ongoing effort to develop and apply a similar approach to chemical mixtures using in vitro cell culture (Syrian hamster embryo cell transformation assay and human keratinocytes) methodologies and in vivo studies. The promise and pitfalls of these developments are elaborated. When successfully applied, these approaches may greatly reduce animal usage, personnel, resources, and time required to evaluate the carcinogenicity of chemicals and chemical mixtures.
Similar articles
-
The use of physiologically-based pharmacokinetic/pharmacodynamic dosimetry models for chemical mixtures.Toxicol Lett. 1995 Dec;82-83:497-504. doi: 10.1016/0378-4274(95)03579-6. Toxicol Lett. 1995. PMID: 8597101 Review.
-
The application of physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling for exploring risk assessment approaches of chemical mixtures.Toxicol Lett. 1995 Sep;79(1-3):193-200. doi: 10.1016/0378-4274(95)03370-z. Toxicol Lett. 1995. PMID: 7570656 Review.
-
Physiologically based pharmacokinetic/pharmacodynamic modeling of chemical mixtures and possible applications in risk assessment.Toxicology. 1995 Dec 28;105(2-3):275-82. doi: 10.1016/0300-483x(95)03222-2. Toxicology. 1995. PMID: 8571364
-
Application of biologically based computer modeling to simple or complex mixtures.Environ Health Perspect. 2002 Dec;110 Suppl 6(Suppl 6):957-63. doi: 10.1289/ehp.02110s6957. Environ Health Perspect. 2002. PMID: 12634125 Free PMC article. Review.
-
Integrated approaches for the analysis of toxicologic interactions of chemical mixtures.Crit Rev Toxicol. 1997 Mar;27(2):175-97. doi: 10.3109/10408449709021618. Crit Rev Toxicol. 1997. PMID: 9099518 Review.
Cited by
-
Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.Curr Drug Metab. 2012 Jul;13(6):863-80. doi: 10.2174/138920012800840419. Curr Drug Metab. 2012. PMID: 22571482 Free PMC article. Review.
-
A docking-based receptor library of antibiotics and its novel application in predicting chronic mixture toxicity for environmental risk assessment.Environ Monit Assess. 2013 Jun;185(6):4513-27. doi: 10.1007/s10661-012-2885-5. Epub 2012 Nov 11. Environ Monit Assess. 2013. PMID: 23143826
-
Perils of paradigm: complexity, policy design, and the Endocrine Disruptor Screening Program.Environ Health. 2005 Feb 8;4(1):2. doi: 10.1186/1476-069X-4-2. Environ Health. 2005. PMID: 15701170 Free PMC article.
-
Recent Progress on Physiologically Based Pharmacokinetic (PBPK) Model: A Review Based on Bibliometrics.Toxics. 2024 Jun 14;12(6):433. doi: 10.3390/toxics12060433. Toxics. 2024. PMID: 38922113 Free PMC article. Review.
-
Advancing understanding of human variability through toxicokinetic modeling, in vitro-in vivo extrapolation, and new approach methodologies.Hum Genomics. 2024 Nov 21;18(1):129. doi: 10.1186/s40246-024-00691-9. Hum Genomics. 2024. PMID: 39574200 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources